CIMAB SA, 20 Years in Cuban Biotechnology
News | 12 June 2012
This is the first vaccine against this kind of cancer registered worldwide. It has been registered in Cuba, Canada, the United States, Japan and South Africa, among other countries. CIMAB SA , 20 Years in Cuban Biotechnology.
Click on the link to read the full article at Solvisi
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
